2m 2m 2m 2m 2m 2m 2m
Rein Therap (RNTX)
NASDAQ
$0.96-$0.010 (-0.99%)
Price as of Jun 23, 2026 5:54 PM EDT- $77.3MMarket Cap
- -34.11%1-Year Change
- BiotechnologyIndustry
Rein Therap (RNTX)
$0.96-$0.010 (-0.99%)
RNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.97 | ||
Change | +$0.06 (+7.16%) | ||
Open | $0.91 | ||
High | $1.02 | ||
Low | $0.91 | ||
Previous Close | $0.90 | ||
Volume | 447,032 | ||
30-Day Average Volume | 607,767 | ||
1-Week Change | 2.50% | ||
1-Month Change | -5.96% | ||
1-Year Change | -34.11% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 85.5M | ||
Total Assets | $26.3M | ||
Market Cap | $77.3M | ||
Enterprise Value | $77.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.8M | ||
Free Cash Flow | -$3.4M | ||
EBIT | -$5.8M | ||
EBITDA | -$5.8M | ||
Net Working Capital | -$8.2M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue